Capricor Therapeutics, Inc. (CAPR) Press Releases https://www.capricor.com/investors/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/capricor/files/theme/images/logo-sm.png Capricor Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel]]> https://www.capricor.com/investors/news-events/press-releases/detail/351/capricor-therapeutics-provides-update-on-fda-advisory Thu, 30 Jul 26 09:30:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/351/capricor-therapeutics-provides-update-on-fda-advisory <![CDATA[The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy]]> https://www.capricor.com/investors/news-events/press-releases/detail/350/the-lancet-publishes-hope-3-data-for-capricor Wed, 29 Jul 26 10:05:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/350/the-lancet-publishes-hope-3-data-for-capricor <![CDATA[Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel]]> https://www.capricor.com/investors/news-events/press-releases/detail/349/capricor-comments-on-briefing-materials-ahead-of-july-29 Mon, 27 Jul 26 11:00:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/349/capricor-comments-on-briefing-materials-ahead-of-july-29 <![CDATA[Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy]]> https://www.capricor.com/investors/news-events/press-releases/detail/348/capricor-therapeutics-announces-fda-advisory-committee Fri, 26 Jun 26 10:02:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/348/capricor-therapeutics-announces-fda-advisory-committee <![CDATA[Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference]]> https://www.capricor.com/investors/news-events/press-releases/detail/347/capricor-to-present-positive-five-year-hope-2-ole-data-and Fri, 26 Jun 26 09:05:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/347/capricor-to-present-positive-five-year-hope-2-ole-data-and <![CDATA[Capricor Therapeutics to Present at Upcoming Investor Conferences]]> https://www.capricor.com/investors/news-events/press-releases/detail/346/capricor-therapeutics-to-present-at-upcoming-investor Mon, 08 Jun 26 09:25:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/346/capricor-therapeutics-to-present-at-upcoming-investor <![CDATA[Capricor Therapeutics Expands Commercial Leadership Team]]> https://www.capricor.com/investors/news-events/press-releases/detail/345/capricor-therapeutics-expands-commercial-leadership-team Thu, 28 May 26 21:55:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/345/capricor-therapeutics-expands-commercial-leadership-team <![CDATA[Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update]]> https://www.capricor.com/investors/news-events/press-releases/detail/344/capricor-therapeutics-reports-first-quarter-2026-financial Tue, 12 May 26 16:05:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/344/capricor-therapeutics-reports-first-quarter-2026-financial <![CDATA[Capricor Therapeutics Takes Legal Action to Protect Patient Access to Deramiocel for Duchenne Muscular Dystrophy]]> https://www.capricor.com/investors/news-events/press-releases/detail/343/capricor-therapeutics-takes-legal-action-to-protect-patient Thu, 07 May 26 17:00:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/343/capricor-therapeutics-takes-legal-action-to-protect-patient <![CDATA[Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12]]> https://www.capricor.com/investors/news-events/press-releases/detail/342/capricor-therapeutics-to-report-first-quarter-2026 Mon, 04 May 26 16:05:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/342/capricor-therapeutics-to-report-first-quarter-2026